DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, DaVita Inc. (DVA) trades at a price to free cash flow of 6.7×. Over the past ten years it has ranged from 1.5× (April 2020) to 41.7× (November 2015); the current reading is higher than 30% of that period. That is below the Medical Care Facilities industry median of 13.7× and below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 5.6× (27.20%)
FY2024 7.6× 36.07%
FY2023 5.6× (8.25%)
FY2022 6.1× (31.12%)
FY2021 8.9× (14.60%)
FY2020 10.4× 368.49%
FY2019 2.2× (76.44%)
FY2018 9.4× (24.38%)
FY2017 12.4× 14.45%
FY2016 10.9× (36.08%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 8.0× 30.95%
Mar 2026 6.1× 10.12%
Dec 2025 5.6× (12.65%)
Sep 2025 6.4× (12.00%)
42 more quarters

Against its own ten years

Low 1.5× High 41.7×
Ten-year median 8.5×
Current reading's percentile 30

Price to free cash flow against peers

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on DVA